These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 1980362)
41. [Current developments in the pharmacology of dopaminergic receptors (I)]. Nechifor M; Lucaci L Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):143-4. PubMed ID: 2573121 [No Abstract] [Full Text] [Related]
42. [Current developments in the pharmacology of dopaminergic receptors (II)]. Nechifor M Rev Med Chir Soc Med Nat Iasi; 1989; 93(2):393-4. PubMed ID: 2573123 [No Abstract] [Full Text] [Related]
43. [Current developments in the pharmacology of the dopaminergic receptors. III]. Nechifor M; Lucaci L Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):510, 516, 566. PubMed ID: 2576889 [No Abstract] [Full Text] [Related]
44. Regression estimation from grouped observations applied to structurally diverse D2-receptor antagonists. Mager PP; Rothe H Pharmazie; 1990 Jun; 45(6):424-33. PubMed ID: 1976263 [TBL] [Abstract][Full Text] [Related]
51. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure. Goldberg LI J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S21-8. PubMed ID: 2483439 [TBL] [Abstract][Full Text] [Related]
52. Dopaminergic drugs in the cationic form interact with D2 dopamine receptors. Miller DD; Harrold M; Wallace RA; Wallace LJ; Uretsky NJ Trends Pharmacol Sci; 1988 Aug; 9(8):282-4. PubMed ID: 2907954 [No Abstract] [Full Text] [Related]